Diana Hausman, Chief Medical Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 3,356 shares at $12.62 ($42K) on 2024-05-09, disclosed to the SEC on 2024-05-09.
Open-market sale of $42k ZNTL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZYME | SELL | 2020-12-04 | $665K | — | Filing → |
| ZYME | SELL | 2020-12-03 | $2.1M | — | Filing → |
| ZYME | SELL | 2020-09-16 | $1.8M | — | Filing → |